1. Home
  2. MCB vs EVMN Comparison

MCB vs EVMN Comparison

Compare MCB & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

HOLD

Current Price

$88.50

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

EVMN

Evommune Inc.

N/A

Current Price

$23.70

Market Cap

914.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MCB
EVMN
Founded
1999
2020
Country
United States
United States
Employees
N/A
48
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
914.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
MCB
EVMN
Price
$88.50
$23.70
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$98.67
$43.88
AVG Volume (30 Days)
158.5K
248.7K
Earning Date
04-21-2026
06-11-2026
Dividend Yield
1.13%
N/A
EPS Growth
11.64
N/A
EPS
6.62
N/A
Revenue
$11,053,000.00
N/A
Revenue This Year
$37.22
N/A
Revenue Next Year
$14.75
N/A
P/E Ratio
$13.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$62.58
$13.89
52 Week High
$97.84
$33.20

Technical Indicators

Market Signals
Indicator
MCB
EVMN
Relative Strength Index (RSI) 50.73 42.81
Support Level $86.02 $21.14
Resistance Level $97.29 $25.50
Average True Range (ATR) 2.76 1.69
MACD -0.22 -0.44
Stochastic Oscillator 26.99 8.38

Price Performance

Historical Comparison
MCB
EVMN

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: